| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Jun 24 | ACRS Aclaris Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 4,793 | 0.00 | 4,793 |
| 6 Jun 24 | ACRS Aclaris Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.03 | 15,750 | 16.22 k | 15,750 |
| 1 Jun 24 | ACRS Aclaris Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 4,660 | 0.00 | 16,961 |
| 1 Jun 24 | ACRS Aclaris Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 4,660 | 0.00 | 0 |
| 21 May 24 | PASG Passage Bio | Director Stock Option Common Stock | Grant | Acquire A | No | No | 1.28 | 47,693 | 61.05 k | 47,693 |
| 7 May 24 | MRUS Merus | Share Option Common Shares | Grant | Acquire A | No | No | 48.73 | 8,844 | 430.97 k | 8,844 |
| 10 Aug 23 | ACGN Aceragen | Common Stock | Sell | Dispose S | Yes | No | 0.51 | 51 | 26.01 | 0 |
